![]() |
市场调查报告书
商品编码
1570571
采血市场、机会、成长动力、产业趋势分析与预测,2024-2032Blood Collection Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032 |
2023 年全球血液采集市场价值约为109 亿美元,预计2024 年至2032 年复合年增长率为6.9%。血液采集。这个市场是由心血管疾病、糖尿病、呼吸系统疾病和癌症等慢性疾病盛行率上升所推动的。技术进步、外科手术的增加以及老年人口的增加进一步推动了市场的成长。自动采血系统可减少人为错误并提高患者的舒适度。这些系统,包括自动静脉穿刺设备,使用机器人技术和先进的成像技术来实现精确和一致的抽血。
整个采血产业根据车辆、产品类型、毛细管、方法、应用、最终用途和地区进行分类。
市场依产品类型分为静脉和微血管。静脉部分包括针头和注射器、采血管、血袋和其他产品。毛细血管部分包括采血针、微容器管、微血细胞比容管、加温装置和其他产品。到 2032 年,静脉部分预计将达到 127 亿美元。
静脉血液采集可产生更大的体积,这对于综合测试和多重分析至关重要。静脉样本支持广泛的诊断测试,包括生物化学、血液学、血清学和分子诊断。它们可以被分离成血浆或血清以进行专门测试。静脉样本更加一致和可靠,对于准确诊断和长期研究至关重要。与毛细管样本相比,静脉样本面临的溶血和污染等问题较少。
市场也依方法分为手动和自动采血。 2023 年,手排部分的销售额为 71 亿美元。注射器、针头和刺血针等手动工具便于携带,非常适合偏远地区、家访或紧急情况。手动方法具有成本效益,需要最少的设备,使其适用于资源有限的环境。
到 2032 年,美国血液采集市场预计将达到 73 亿美元。心血管疾病、糖尿病、呼吸系统疾病和癌症等慢性疾病盛行率的上升推动了市场的成长。 CDC 报告 2020 年美国新增癌症病例 1,603,844 例,死亡人数 602,347 人
The Global Blood Collection Market was valued at approximately USD 10.9 billion in 2023 and is projected to grow at a CAGR of 6.9% from 2024 to 2032. Blood collection is crucial in healthcare for diagnosis, treatment, and research, involving venipuncture, fingerstick, or arterial draws. The market is driven by the rising prevalence of chronic diseases like cardiovascular ailments, diabetes, respiratory issues, and cancer. Technological advancements, an increase in surgical procedures, and a growing geriatric population further fuel market growth. Automated blood collection systems reduce human error and enhance patient comfort. These systems, including automated venipuncture devices, use robotics and advanced imaging for precise and consistent blood draws.
The overall blood collection industry is classified based on the vehicle, product type, capillary, method, application, end-use and region.
The market is segmented by product type into venous and capillary. The venous segment includes needles and syringes, blood collection tubes, blood bags, and other products. The capillary segment includes lancets, micro-container tubes, micro-hematocrit tubes, warming devices, and other products. The venous segment is projected to reach USD 12.7 billion by 2032.
Venous blood collection yields larger volumes, essential for comprehensive tests and multiple analyses. Venous samples support a wide range of diagnostic tests, including biochemistry, hematology, serology, and molecular diagnostics. They can be fractionated into plasma or serum for specialized tests. Venous samples are more consistent and reliable, crucial for accurate diagnostics and long-term studies. Venous samples face fewer issues like hemolysis and contamination compared to capillary samples.
The market is also segmented by method into manual and automated blood collection. The manual segment accounted for USD 7.1 billion in 2023. Manual techniques like venipuncture and fingerstick are easily performed with basic training, allowing quick responses to diverse patient needs. Manual tools, such as syringes, needles, and lancets, are portable and ideal for remote areas, home visits, or emergencies. Manual methods are cost-effective, requiring minimal equipment, making them viable for resource-limited settings.
The U.S. blood collection market is projected to reach USD 7.3 billion by 2032. The U.S. leads in healthcare technology and innovation, benefiting from advancements in blood collection technologies like automated venipuncture systems and microfluidic devices. The rising prevalence of chronic diseases, including cardiovascular ailments, diabetes, respiratory issues, and cancer, drives market growth. In 2020, the CDC reported 1,603,844 new cancer cases and 602,347 fatalities in the U.S.